Approval · Notice of Compliance 16677 · 2015
FOSRENOL: Notice of Compliance 16677
Issued March 9, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 16677
- Date
- March 9, 2015
- Company
- Shire Pharma Canada UlcToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Phosphate binder
Products in this notice
Medicinal ingredients
- LANTHANUM CARBONATE HYDRATE 250 MG per TAB
- LANTHANUM CARBONATE HYDRATE 500 MG per TAB
- LANTHANUM CARBONATE HYDRATE 750 MG per TAB
- LANTHANUM CARBONATE HYDRATE 1,000 MG per TAB